Alameda, CA, United States of America

Craig Rice

This inventor holds 1 USPTO granted patent. Top assignee: Codon. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Craig Rice: Innovator in Tissue Plasminogen Activator Recovery

Introduction

Craig Rice is a notable inventor based in Alameda, CA (US). He has made significant contributions to the field of biotechnology, particularly in the recovery of tissue plasminogen activator (t-PA). His innovative methods have the potential to enhance pharmaceutical applications and improve patient outcomes.

Latest Patents

Craig Rice holds a patent for "Methods for recovery of tissue plasminogen activator." This patent discloses methods for recovering t-PA from a liquid medium. The methods involve contacting a liquid medium with at least one substrate capable of effecting a separation of intact t-PA from degraded t-PA. Subsequently, the intact t-PA is recovered free from other unrelated proteins. The invention also provides compounds produced by this method, which include intact one-chain t-PA and pharmaceutical compositions containing them, along with methods for using such compositions.

Career Highlights

Craig Rice is associated with Codon, where he applies his expertise in biotechnology and patent development. His work focuses on advancing methods that can significantly impact the medical field, particularly in the treatment of conditions requiring t-PA.

Collaborations

Craig has collaborated with notable colleagues, including Michael John Morser and Charles Glaser. Their combined efforts contribute to the innovative research and development within their field.

Conclusion

Craig Rice's contributions to the recovery of tissue plasminogen activator exemplify the importance of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for improving therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…